Cannabinoid receptor expression in HIV encephalitis and HIV‐associated neuropathologic comorbidities

M. A. Cosenza‐Nashat, A. Bauman, M.‐L. Zhao, S. Morgello, H.‐S. Suh and S. C. Lee (2011) Neuropathology and Applied Neurobiology37, 464–483

[1]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[2]  H. Gendelman,et al.  Immunoregulation of a CB2 Receptor Agonist in a Murine Model of NeuroAIDS , 2010, Journal of Neuroimmune Pharmacology.

[3]  M. Itokawa,et al.  Brain Cannabinoid CB2 Receptor in Schizophrenia , 2010, Biological Psychiatry.

[4]  J. Sallés,et al.  Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas , 2010, Neurochemistry International.

[5]  K. Mackie,et al.  Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ* , 2010, The Journal of Biological Chemistry.

[6]  E. Cudaback,et al.  The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas , 2010, PloS one.

[7]  Paul F. Smith,et al.  Cannabinoids in the treatment of cancer. , 2009, Cancer letters.

[8]  William M. Lee,et al.  Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes , 2009, ASN neuro.

[9]  Í. Azcoitia,et al.  Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. , 2009, Brain : a journal of neurology.

[10]  C. Newton,et al.  Identification of Transcription Start Sites and Preferential Expression of Select CB2 Transcripts in Mouse and Human B Lymphocytes , 2009, Journal of Neuroimmune Pharmacology.

[11]  G. Uhl,et al.  Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands , 2009, Genes, brain, and behavior.

[12]  M. Dusch,et al.  Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans , 2009, Brain Research Bulletin.

[13]  S. Isezuo,et al.  Clinical neuropathy in HIV/AIDS: an eight-year review of hospitalized patients in Sokoto, northwestern Nigeria , 2009, Tropical doctor.

[14]  Sunhee C. Lee,et al.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain , 2009, Neuropathology and applied neurobiology.

[15]  L. Hunyady,et al.  Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors* , 2009, The Journal of Biological Chemistry.

[16]  J. Alferink,et al.  Interferon-γ Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain , 2008, The Journal of Neuroscience.

[17]  A. Brusco,et al.  Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors , 2008, Annals of the New York Academy of Sciences.

[18]  P. Dubový,et al.  Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review , 2008, Pharmacology Biochemistry and Behavior.

[19]  E. Hermans,et al.  Differential modulation of AP‐1‐ and CRE‐driven transcription by cannabinoid agonists emphasizes functional selectivity at the CB1 receptor , 2008, British journal of pharmacology.

[20]  G. Cabral,et al.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. , 2008, Endocrine, metabolic & immune disorders drug targets.

[21]  A. Araque,et al.  Endocannabinoids Mediate Neuron-Astrocyte Communication , 2008, Neuron.

[22]  F. Bermúdez-Silva,et al.  Presence of functional cannabinoid receptors in human endocrine pancreas , 2008, Diabetologia.

[23]  J. Kraus,et al.  Activation of Human T Cells Induces Upregulation of Cannabinoid Receptor Type 1 Transcription , 2008, Neuroimmunomodulation.

[24]  W. Griffin,et al.  Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome , 2008, Neuroscience.

[25]  J. Romero,et al.  Cannabinoid CB2 receptors in human brain inflammation , 2008, British journal of pharmacology.

[26]  C. Marras,et al.  Expression of cannabinoid receptors and neurotrophins in human gliomas , 2007, Neurological Sciences.

[27]  N. McGrath,et al.  FREQUENCY OF AND RISK FACTORS FOR HIV DEMENTIA IN AN HIV CLINIC IN SUB-SAHARAN AFRICA , 2007, Neurology.

[28]  M. Glass,et al.  The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. , 2007, Current neuropharmacology.

[29]  B. Kamińska,et al.  Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors , 2007, Brain Research.

[30]  D. Clemente,et al.  Cannabinoid CB1 and CB2 Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis , 2007, The Journal of Neuroscience.

[31]  W. Sebald,et al.  Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids , 2007, Journal of leukocyte biology.

[32]  J. Sallés,et al.  Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates , 2006, Neuroscience.

[33]  Sunhee C. Lee,et al.  CD45 Isoform Expression in Microglia and Inflammatory Cells in HIV‐1 Encephalitis , 2006, Brain pathology.

[34]  G. Uhl,et al.  Discovery of the Presence and Functional Expression of Cannabinoid CB2 Receptors in Brain , 2006, Annals of the New York Academy of Sciences.

[35]  G. Velasco,et al.  Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development. , 2006, Current pharmaceutical design.

[36]  R. Nitsch,et al.  The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells , 2006, Neuron.

[37]  C. Fowler.  Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptors. , 2005, Current drug targets. CNS and neurological disorders.

[38]  I. Grant,et al.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges , 2005, Clinical Neuroscience Research.

[39]  E. Ponomarev,et al.  Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli , 2005, Journal of neurochemistry.

[40]  K. Mackie,et al.  A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis , 2005, The Journal of Neuroscience.

[41]  G. Uhl,et al.  Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse , 2004, Molecular Psychiatry.

[42]  A. Barbáchano,et al.  Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: An immunohistochemical study , 2004, Synapse.

[43]  W. Campbell,et al.  Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. , 2004, Molecular pharmacology.

[44]  T. Möller,et al.  P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Alberto Rábano,et al.  Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains , 2003, The Journal of Neuroscience.

[46]  N. Stella,et al.  Endothelin‐1 increases 2‐arachidonoyl glycerol (2‐AG) production in astrocytes , 2003, Glia.

[47]  Alexander J Stokes,et al.  Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells1 , 2003, The Journal of Immunology.

[48]  R. Beschorner.  Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. , 2003, Brain pathology.

[49]  Sunhee C. Lee,et al.  Up‐regulation of MAP2e‐expressing oligodendrocytes in the white matter of patients with HIV‐1 encephalitis , 2002, Neuropathology and applied neurobiology.

[50]  N. Sacktor.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[51]  M. L. de Ceballos,et al.  Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2002, The Journal of Biological Chemistry.

[52]  I. Matias,et al.  Presence and regulation of the endocannabinoid system in human dendritic cells. , 2002, European journal of biochemistry.

[53]  E. Fride.  Endocannabinoids in the central nervous system--an overview. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[54]  H. Romijn,et al.  Double Immunolabeling of Neuropeptides in the Human Hypothalamus as Analyzed by Confocal Laser Scanning Fluorescence Microscopy , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[55]  S. Galiègue,et al.  Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. , 1998, Blood.

[56]  A. Howlett,et al.  Rat brain cannabinoid receptors are N-linked glycosylated proteins. , 1995, Life sciences.

[57]  D. Dickson,et al.  Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[58]  Thea Mulder-Krieger,et al.  The endocannabinoid 2-arachidonylglycerol is a negative allosteric modulator of the human A3 adenosine receptor. , 2010, Biochemical pharmacology.

[59]  J. Pollard,et al.  Immunopathology and Infectious Diseases Insulin-Like Growth Factor 2 Receptor Is an IFN-Inducible Microglial Protein that Facilitates Intracellular HIV Replication Implications for HIV-Induced Neurocognitive Disorders , 2010 .

[60]  A. Malfitano,et al.  Cannabinoid receptor CB1 antagonists state of the art and challenges. , 2009, Vitamins and hormones.

[61]  F. Fezza,et al.  Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. , 2008, Sub-cellular biochemistry.

[62]  B. Cravatt,et al.  The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells , 2006, The Journal of Neuroscience.

[63]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[64]  E.E. Pissaloux,et al.  Image Processing , 1994, Proceedings. Second Euromicro Workshop on Parallel and Distributed Processing.